3Hans-Henrikp, Rutho, Eberhard R. Diabetic Nephropa2thy. In: Barry MB [M]. The Kidney 6th ed. Philadelphia : Sauders, 2000,1732
4陈灏珠.实用内科学.人民卫生出版社,2004,3(11):1863-1865.
5Kim JH, Oh SJ, Lee JM, etc. The effect of an Angiotensin receptor blocker on arterial stiff-ness in type 2 diabetes mellitus patients with hypertension[ J ]. Diabetes Metab J, 2011,35 (3) :236 -242.
6Jiao B, Wang YS, Cheng YN, etc. Valsartan at- tenuated oxidative stress, decreased MCP - 1 and TGF - 131 expression in glomerular me- sangial and epithelial cells induced by high - glucose levels [ J]. Biosci Trends ,2011,5 (4) : 173 - 181.
7Iwashita M, Sakoda H, Kushiyama A, etc, Val- sartan, independently of AT1 receptor or PPAR, suppresses LPS - induced macrophage activation and improves insulin resistance in eocultured adipocytes [ J ]. Am J Physiol Endo- crinol Metab ,2012,302(3 ) :286 - 296.
